HSIC
Henry Schein, Inc. NASDAQ Listed Nov 3, 1995$79.92
After hrs
$79.92
+0.00%
Mkt Cap $9.7B
52w Low $62.03
83.9% of range
52w High $83.35
50d MA $75.80
200d MA $73.66
P/E (TTM)
24.4x
EV/EBITDA
12.1x
P/B
2.0x
Debt/Equity
1.1x
ROE
12.3%
P/FCF
17.0x
RSI (14)
66.20
ATR (14)
$1.60
Beta
0.88
50d MA
$75.80
200d MA
$73.66
Avg Volume
1.6M
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
135 Duryea Road · Melville, NY 11747 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | TNS | 1.20 | 1.32 | +10.0% | 74.37 | +1.0% | -2.6% | -2.7% | +0.5% | -2.6% | +0.5% | — |
| Feb 24, 2026 | TNS | 1.30 | 1.34 | +3.1% | 83.35 | -0.9% | -1.7% | +0.0% | -0.5% | +1.1% | -1.2% | — |
| Nov 4, 2025 | TNS | 1.27 | 1.38 | +8.7% | 71.61 | -0.2% | +0.6% | +0.0% | -2.7% | +2.6% | +1.5% | — |
| Aug 5, 2025 | TNS | 1.18 | 1.10 | -6.8% | 64.83 | -0.0% | +2.3% | +0.0% | -0.6% | +0.1% | +0.2% | — |
| May 5, 2025 | TNS | 1.11 | 1.15 | +3.6% | 66.58 | +0.6% | -0.5% | +0.0% | +0.5% | +3.5% | -0.4% | — |
| Feb 25, 2025 | TNS | 1.23 | 1.19 | -3.3% | 75.82 | +0.1% | -4.3% | +0.0% | -0.6% | +0.1% | -1.9% | — |
| Nov 5, 2024 | TNS | 1.16 | 1.22 | +5.2% | 68.99 | +2.9% | +1.5% | +0.0% | -0.8% | -2.1% | +0.4% | — |
| Aug 6, 2024 | TNS | 1.22 | 1.23 | +0.8% | 63.92 | +1.4% | +2.9% | +0.0% | +3.6% | +1.1% | -1.5% | — |
| May 7, 2024 | TNS | 1.02 | 1.10 | +7.8% | 71.20 | +0.5% | +2.2% | +0.0% | +0.9% | -0.2% | -0.2% | — |
| Feb 27, 2024 | TNS | 0.70 | 0.66 | -5.7% | 77.85 | +0.4% | -1.7% | +0.0% | -0.0% | +0.5% | -0.1% | — |
| Nov 13, 2023 | TNS | 1.32 | 1.32 | +0.0% | 67.50 | +0.8% | +2.1% | +0.0% | -1.9% | +1.7% | -0.0% | — |
| Aug 7, 2023 | TNS | 1.28 | 1.31 | +2.3% | 75.87 | -0.3% | +0.1% | +0.0% | +1.9% | -1.2% | +0.2% | — |
| May 9, 2023 | BMO | 1.24 | 1.21 | -2.4% | 74.83 | +0.6% | +1.9% | +0.0% | +0.9% | -0.7% | +2.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 | BTIG Research | Upgrade | Neutral → Buy | $100 | $78.85 | $80.06 | +1.5% | +1.7% | +1.3% | -0.2% | +0.1% | -1.5% |
| Apr 24 | Morgan Stanley | Maintains | Underweight → Underweight | — | $78.22 | $78.02 | -0.3% | -0.9% | -0.4% | -1.4% | -3.0% | +1.1% |
| Apr 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $73.85 | $73.91 | +0.1% | +2.3% | +0.1% | -0.4% | +0.9% | +1.6% |
| Feb 25 | Barrington Research | Maintains | Outperform → Outperform | — | $83.35 | $82.58 | -0.9% | -1.7% | -0.5% | +1.1% | -1.2% | -1.4% |
| Feb 25 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $83.35 | $82.58 | -0.9% | -1.7% | -0.5% | +1.1% | -1.2% | -1.4% |
| Feb 25 | JP Morgan | Maintains | Overweight → Overweight | — | $83.35 | $82.58 | -0.9% | -1.7% | -0.5% | +1.1% | -1.2% | -1.4% |
| Feb 25 | Mizuho | Maintains | Neutral → Neutral | — | $83.35 | $82.58 | -0.9% | -1.7% | -0.5% | +1.1% | -1.2% | -1.4% |
| Feb 25 | Evercore ISI | Maintains | Outperform → Outperform | — | $83.35 | $82.58 | -0.9% | -1.7% | -0.5% | +1.1% | -1.2% | -1.4% |
| Feb 25 | UBS | Maintains | Neutral → Neutral | — | $83.35 | $82.58 | -0.9% | -1.7% | -0.5% | +1.1% | -1.2% | -1.4% |
| Feb 25 | Morgan Stanley | Maintains | Underweight → Underweight | — | $83.35 | $82.58 | -0.9% | -1.7% | -0.5% | +1.1% | -1.2% | -1.4% |
| Feb 24 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $80.57 | $84.00 | +4.3% | +3.5% | -1.7% | -0.5% | +1.1% | -1.2% |
| Feb 23 | Baird | Upgrade | Neutral → Outperform | — | $79.57 | $81.60 | +2.6% | +1.3% | +3.5% | -1.7% | -0.5% | +1.1% |
| Jan 20 | Mizuho | Maintains | Neutral → Neutral | — | $79.98 | $79.69 | -0.4% | -2.8% | +1.6% | -0.6% | -1.6% | +0.5% |
| Nov 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.7% | +2.6% | +1.5% | +0.3% |
| Nov 5 | Barrington Research | Maintains | Outperform → Outperform | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.7% | +2.6% | +1.5% | +0.3% |
| Nov 5 | Morgan Stanley | Maintains | Underweight → Underweight | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.7% | +2.6% | +1.5% | +0.3% |
| Nov 5 | Evercore ISI | Maintains | Outperform → Outperform | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.7% | +2.6% | +1.5% | +0.3% |
| Nov 5 | JP Morgan | Maintains | Overweight → Overweight | — | $71.61 | $71.49 | -0.2% | +0.6% | -2.7% | +2.6% | +1.5% | +0.3% |
| Oct 22 | Barrington Research | Maintains | Outperform → Outperform | — | $64.23 | $64.23 | +0.0% | -1.1% | +0.1% | +0.4% | -0.5% | -0.5% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $67.92 | $68.13 | +0.3% | +1.9% | -2.1% | -3.1% | +0.6% | -0.0% |
| Aug 26 | Evercore ISI | Upgrade | In Line → Outperform | — | $68.47 | $69.80 | +1.9% | +0.9% | -0.1% | +0.1% | +0.8% | -1.7% |
| Aug 7 | JP Morgan | Maintains | Overweight → Overweight | — | $66.32 | $67.08 | +1.1% | -0.6% | +0.1% | +0.2% | +2.1% | +2.2% |
| Aug 6 | Barrington Research | Maintains | Outperform → Outperform | — | $64.83 | $64.82 | -0.0% | +2.3% | -0.6% | +0.1% | +0.2% | +2.1% |
| Aug 6 | Evercore ISI | Maintains | In Line → In Line | — | $64.83 | $64.82 | -0.0% | +2.3% | -0.6% | +0.1% | +0.2% | +2.1% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $64.83 | $64.82 | -0.0% | +2.3% | -0.6% | +0.1% | +0.2% | +2.1% |
| Jul 25 | Stifel | Downgrade | Buy → Hold | — | $72.62 | $71.96 | -0.9% | -1.6% | -1.4% | -0.6% | -0.7% | -2.8% |
| Jul 14 | Baird | Downgrade | Outperform → Neutral | — | $73.42 | $70.38 | -4.1% | -3.7% | -0.1% | -1.9% | +0.3% | -0.6% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $73.95 | $74.54 | +0.8% | +0.3% | +0.5% | -1.5% | -3.7% | -0.1% |
| May 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $66.58 | $66.97 | +0.6% | -0.5% | +0.5% | +3.5% | -0.4% | +2.7% |
| May 6 | Barrington Research | Maintains | Outperform → Outperform | — | $66.58 | $66.97 | +0.6% | -0.5% | +0.5% | +3.5% | -0.4% | +2.7% |
| Apr 30 | Piper Sandler | Maintains | Overweight → Overweight | — | $66.16 | $65.39 | -1.2% | -1.8% | -0.8% | +1.3% | +2.0% | -0.5% |
| Feb 26 | Barrington Research | Maintains | Outperform → Outperform | — | $75.82 | $75.88 | +0.1% | -4.3% | -0.6% | +0.1% | -1.9% | -0.7% |
| Feb 26 | UBS | Maintains | Neutral → Neutral | — | $75.82 | $75.88 | +0.1% | -4.3% | -0.6% | +0.1% | -1.9% | -0.7% |
| Jan 30 | Barrington Research | Maintains | Outperform → Outperform | — | $79.87 | $80.46 | +0.7% | +0.2% | -0.0% | -0.5% | +1.3% | +1.7% |
| Jan 23 | Jefferies | Maintains | Hold → Hold | — | $74.78 | $75.37 | +0.8% | -0.0% | +0.3% | +2.3% | -0.8% | +5.0% |
| Jan 6 | BofA Securities | Upgrade | Underperform → Buy | — | $69.09 | $71.59 | +3.6% | +3.9% | -0.1% | -0.9% | -2.0% | +1.5% |
| Nov 6 | Barrington Research | Maintains | Outperform → Outperform | — | $68.99 | $71.00 | +2.9% | +1.5% | -0.8% | -2.1% | +0.4% | -1.2% |
| Oct 8 | Evercore ISI | Maintains | In Line → In Line | — | $69.30 | $69.34 | +0.1% | +1.0% | +0.7% | -0.7% | +0.7% | +0.7% |
| Sep 20 | Barrington Research | Maintains | Outperform → Outperform | — | $72.54 | $72.31 | -0.3% | -1.9% | +0.7% | -1.3% | -1.2% | +1.5% |
| Aug 12 | JP Morgan | Maintains | Overweight → Overweight | — | $68.94 | $68.40 | -0.8% | -1.5% | +2.3% | -1.3% | +1.9% | +0.0% |
| Aug 7 | Barrington Research | Maintains | Outperform → Outperform | — | $63.92 | $64.81 | +1.4% | +2.9% | +3.6% | +1.1% | -1.5% | +2.3% |
| Aug 7 | UBS | Maintains | Neutral → Neutral | — | $63.92 | $64.81 | +1.4% | +2.9% | +3.6% | +1.1% | -1.5% | +2.3% |
| Aug 7 | Evercore ISI | Maintains | In Line → In Line | — | $63.92 | $64.81 | +1.4% | +2.9% | +3.6% | +1.1% | -1.5% | +2.3% |
| Aug 7 | Baird | Maintains | Outperform → Outperform | — | $63.92 | $64.81 | +1.4% | +2.9% | +3.6% | +1.1% | -1.5% | +2.3% |
| Jul 22 | Baird | Upgrade | Neutral → Outperform | — | $70.34 | $71.61 | +1.8% | +0.9% | -1.4% | +0.4% | +1.1% | +1.8% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $64.75 | $64.54 | -0.3% | -0.5% | -0.4% | +1.4% | +0.1% | +1.1% |
| Jul 5 | Barrington Research | Maintains | Outperform → Outperform | — | $64.79 | $64.55 | -0.4% | +0.3% | -0.3% | -0.5% | -0.4% | +1.4% |
| Jun 21 | Piper Sandler | Maintains | Overweight → Overweight | — | $66.55 | $66.78 | +0.3% | +1.1% | +0.0% | -1.7% | -2.3% | -0.7% |
| May 8 | Barrington Research | Maintains | Outperform → Outperform | — | $71.20 | $71.53 | +0.5% | +2.2% | +0.9% | -0.2% | -0.2% | -0.5% |
| May 8 | UBS | Maintains | Neutral → Neutral | — | $71.20 | $71.53 | +0.5% | +2.2% | +0.9% | -0.2% | -0.2% | -0.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | DANIEL WILLIAM K | — | Buy | 10,000 | $69.19 | $692K | 20,000 | +0.14% | +0.32% |
8-K · 7.01
! Medium
Henry Schein, Inc. -- 8-K 7.01: Regulation FD Disclosure
May 22
8-K · 2.02
!! High
Henry Schein, Inc. -- 8-K 2.02: Earnings Results
Henry Schein reported Q1 2026 earnings results, providing investors with updated financial performance metrics to assess the company's operational health and trajectory.
May 5
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The departure of an executive effective April 15, 2026 signals potential leadership uncertainty; investors should monitor whether the replacement demonstrates strategic continuity or signals broader organizational concerns affecting these companies' performance.
Apr 14
8-K
Henry Schein Inc -- 8-K Filing
Henry Schein reported Q4 2025 earnings growth with non-GAAP diluted EPS of $1.34 versus $1.19 year-over-year, while guiding 2026 EPS between $5.23-$5.37 with modest 3-5% sales growth.
Feb 24
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Kohlberg Kravis Roberts & Co. L.p. | 15,652,032 | $1.2B | — | Dec 2025 |
| 2 | Artisan Partners Limited Partnership | 6,573,023 | $484M | Reduced | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 6,423,167 | $473M | New | Mar 2026 |
| 4 | Fmr Llc | 5,722,149 | $422M | Added | Mar 2026 |
| 5 | Invesco Ltd. | 4,886,483 | $360M | Added | Mar 2026 |
| 6 | Jpmorgan Chase & Co | 4,562,512 | $332M | Reduced | Mar 2026 |
| 7 | Vanguard Portfolio Management Llc | 4,194,920 | $309M | New | Mar 2026 |
| 8 | Morgan Stanley | 2,991,204 | $226M | Added | Dec 2025 |
| 9 | Bank Of Montreal /can/ | 2,043,970 | $151M | Reduced | Mar 2026 |
| 10 | Fiduciary Management Inc /wi/ | 1,954,083 | $144M | Reduced | Mar 2026 |
| 11 | Lyrical Asset Management Lp | 1,544,442 | $114M | Reduced | Mar 2026 |
| 12 | Schroder Investment Management Group | 1,514,385 | $110M | Added | Mar 2026 |
| 13 | Swedbank Ab | 1,310,822 | $97M | — | Mar 2026 |
| 14 | Bank Of America Corp /de/ | 1,221,585 | $90M | Reduced | Mar 2026 |
| 15 | Ubs Group Ag | 1,055,466 | $78M | Added | Mar 2026 |
| 16 | Northern Trust Corp | 993,487 | $73M | Added | Mar 2026 |
| 17 | Pzena Investment Management Llc | 887,639 | $65M | — | Mar 2026 |
| 18 | Thompson Siegel & Walmsley Llc | 805,284 | $59M | Reduced | Mar 2026 |
| 19 | Defilade Capital Management, L.p. | 624,037 | $46M | Added | Mar 2026 |
| 20 | Sg Americas Securities, Llc | 606,492 | $45M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$9.73B
Enterprise Value
$12.13B
P/E (TTM)
24.44x
Forward P/E
15.04x
PEG Ratio
3.22x
P/B
2.01x
P/S
0.74x
P/FCF
16.98x
EV/EBITDA
12.06x
Shares Out
121.7M
Financials (TTM)
Revenue
$13.18B
Net Income
$398.0M
EBITDA
$1.01B
Free Cash Flow
$573.0M
Op Cash Flow
$712.0M
EPS Basic
$3.29
EPS Diluted
$3.27
EPS Forward
$5.32
Gross Margin
29.1%
Op Margin
5.8%
Net Margin
3.0%
Balance Sheet
Total Assets
$11.21B
Total Liab.
$6.42B
Total Equity
$4.79B
Cash
$156.0M
LT Debt
$2.56B
Book Value/Sh
$39.68
Debt/Equity
1.14x
Current Ratio
1.38
Quick Ratio
0.76
Returns & Growth
ROE
12.3%
ROA
3.5%
ROIC
6.6%
Rev Growth YoY
+4.0%
EPS Growth YoY
+7.2%
Price Returns
2W
+5.5%
1M
+2.7%
3M
-7.1%
6M
+2.7%
12M
+9.4%
Technicals
52W High
$83.35
52W Low
$62.03
50d MA
$75.80
200d MA
$73.66
RSI (14)
66.20
ATR (14)
$1.60
Beta
0.88
Avg Volume
1.6M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$86.43
High
$100.00
Low
$64.00
Median
$87.00
Data updated apr 25, 2026 2:07pm
· Source: financialmodelingprep.com